Showing results (191-200 of 385) with videos related to

Sort By:
Pageof 39
The Lancet. Neurology|June 21, 2008
MRI in multiple sclerosis: current status and future prospectsRohit Bakshi, Alan J Thompson, Maria A Rocca, et al.
Neuroradiology|December 7, 2014
Diffusion tensor imaging parameters' changes of cerebellar hemispheres in Parkinson's diseaseEnricomaria Mormina, Alessandro Arrigo, Alessandro Calamuneri, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 3, 2023
Perspectives on Neuromyelitis Optica Spectrum Disorders, the Narrative Medicine contribution to careMassimo Filippi, Giovanna Borriello, Francesco Patti, et al.
Frontiers in Neuroscience|April 28, 2023
In-vivo characterization of macro- and microstructural injury of the subventricular zone in relapsing-remitting and progressive multiple sclerosisMaria Cellerino, Simona Schiavi, Caterina Lapucci, et al.
Cornea|August 1, 2020
Neuroaxonal Degeneration in Patients With Multiple Sclerosis: An Optical Coherence Tomography and in Vivo Corneal Confocal Microscopy StudyValeria Testa, Nicole De Santis, Riccardo Scotto, et al.
Headache|January 21, 2025
The "central vein sign" to differentiate multiple sclerosis from migraineGiulia Silvestri, Luca Roccatagliata, Francesco Tazza, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 3, 2026
A proof-of-concept study on the effectiveness of botulinum toxin on spasticity plus syndrome in multiple sclerosisMarcello Moccia, Chiara Clemente, Simone Braca, et al.
Magma (New York, N.Y.)|September 10, 2008
Monitoring demyelination and remyelination by magnetization transfer imaging in the mouse brain at 9.4 TWafaa Zaaraoui, Mathilde Deloire, Michel Merle, et al.
EJNMMI Radiopharmacy and Chemistry|October 30, 2019
Molecular imaging of multiple sclerosis: from the clinical demand to novel radiotracersMatteo Bauckneht, Selene Capitanio, Stefano Raffa, et al.
CNS Drugs|December 11, 2021
Impact of Natural Killer (NK) Cells on Immune Reconstitution, and Their Potential as a Biomarker of Disease Activity, in Alemtuzumab-Treated Patients with Relapsing Remitting Multiple Sclerosis: An Observational StudySerena Palmeri, Marta Ponzano, Federico Ivaldi, et al.
Pageof 39